Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study

Authors: Stelliana Goutzamanis, Joseph S. Doyle, Alexander Thompson, Paul Dietze, Margaret Hellard, Peter Higgs, on behalf of the TAP study group

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

People who inject drugs (PWID) are most at risk of hepatitis C virus infection in Australia. The introduction of transient elastography (TE) (measuring hepatitis fibrosis) and direct acting antiviral medications will likely alter the experience of living with hepatitis C. We aimed to explore positive and negative influences on wellbeing and stress among PWID with hepatitis C.

Methods

The Treatment and Prevention (TAP) study examines the feasibility of treating hepatitis C mono-infected PWID in community settings. Semi-structured interviews were conducted with 16 purposively recruited TAP participants. Participants were aware of their hepatitis C seropositive status and had received fibrosis assessment (measured by TE) prior to interview. Questions were open-ended, focusing on the impact of health status on wellbeing and self-reported stress. Interviews were voice recorded, transcribed verbatim and thematically analysed, guided by Mishel’s (1988) theory of Uncertainty in Illness.

Results

In line with Mishel’s theory of Uncertainty in Illness all participants reported hepatitis C-related uncertainty, particularly mis-information or a lack of knowledge surrounding liver health and the meaning of TE results. Those with greater fibrosis experienced an extra layer of prognostic uncertainty. Experiences of uncertainty were a key motivation to seek treatment, which was seen as a way to regain some stability in life. Treatment completion alleviated hepatitis C-related stress, and promoted feelings of empowerment and confidence in addressing other life challenges.

Conclusion

TE scores seemingly provide some certainty. However, when paired with limited knowledge, particularly among people with severe fibrosis, TE may be a source of uncertainty and increased personal stress. This suggests the need for simple education programs and resources on liver health to minimise stress.
Literature
1.
go back to reference World Health Organisation. Global hepatitis report 2017. Geneva; 2017. Report No.: CC BY-NC-SA 3.0 IGO World Health Organisation. Global hepatitis report 2017. Geneva; 2017. Report No.: CC BY-NC-SA 3.0 IGO
2.
go back to reference Strasser SI, Watson KJ, Lee CS, Coghlan PJ, Desmond PV. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust. 1995;162:355–8.PubMed Strasser SI, Watson KJ, Lee CS, Coghlan PJ, Desmond PV. Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust. 1995;162:355–8.PubMed
3.
go back to reference Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003;26:171–84.CrossRefPubMed Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J Clin Virol. 2003;26:171–84.CrossRefPubMed
5.
go back to reference Chin M, Hogan C, Nguyen D. The natural history of hepatitis C viral infection: clinical evaluation and monitoring. Open Med. 2016;3:52–7.CrossRef Chin M, Hogan C, Nguyen D. The natural history of hepatitis C viral infection: clinical evaluation and monitoring. Open Med. 2016;3:52–7.CrossRef
6.
go back to reference Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553–62.CrossRefPubMed Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10:553–62.CrossRefPubMed
8.
go back to reference Thompson AJ. Australian recommendations for the management of hepatitis C virus infection: a consensus statement. Med J Aust. 2016;204:268–72.CrossRefPubMed Thompson AJ. Australian recommendations for the management of hepatitis C virus infection: a consensus statement. Med J Aust. 2016;204:268–72.CrossRefPubMed
9.
go back to reference Sandrin L, Fourquet B, Hasquenoph J-M, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed Sandrin L, Fourquet B, Hasquenoph J-M, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed
10.
go back to reference European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. Switzerland: European Association for the Study of the Liver; 2016. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. Switzerland: European Association for the Study of the Liver; 2016.
11.
go back to reference Hepatitis C Virus Infection Consensus Statement Working Group. Australian Reccomendations for the management of hepatitis C virus infection: a consensus statement (January 2017). Melbourne: Gastroenterological Society of Australia; 2017. Hepatitis C Virus Infection Consensus Statement Working Group. Australian Reccomendations for the management of hepatitis C virus infection: a consensus statement (January 2017). Melbourne: Gastroenterological Society of Australia; 2017.
14.
go back to reference Harris M. Troubling biographical disruption: narratives of unconcern about hepatitis C diagnosis. Sociol Helath Illn. 2009;31:1028–42.CrossRef Harris M. Troubling biographical disruption: narratives of unconcern about hepatitis C diagnosis. Sociol Helath Illn. 2009;31:1028–42.CrossRef
15.
go back to reference Crockett B, Gifford SM. “Eyes wide shut”: narratives of women living with hepatitis C in Australia. Women Health. 2004;39:117–37.CrossRefPubMed Crockett B, Gifford SM. “Eyes wide shut”: narratives of women living with hepatitis C in Australia. Women Health. 2004;39:117–37.CrossRefPubMed
16.
go back to reference Glacken M, Kernohan G, Coates V. Diagnosed with hepatitis C: a descriptive exploratory study. Int J Nurs Stud. 2001;38:107–16.CrossRefPubMed Glacken M, Kernohan G, Coates V. Diagnosed with hepatitis C: a descriptive exploratory study. Int J Nurs Stud. 2001;38:107–16.CrossRefPubMed
17.
go back to reference Faye B, Irurita V. Balancing perspective: the response to feelings of being condemned with the hepatitis C virus. J Subst Use. 2003;8:92–103.CrossRef Faye B, Irurita V. Balancing perspective: the response to feelings of being condemned with the hepatitis C virus. J Subst Use. 2003;8:92–103.CrossRef
18.
19.
go back to reference Rice VH. Handbook of stress, coping, and health: implications for nursing research, theory, and practice. Thousand Oaks: SAGE Publications Inc; 2000. Rice VH. Handbook of stress, coping, and health: implications for nursing research, theory, and practice. Thousand Oaks: SAGE Publications Inc; 2000.
22.
go back to reference Sanders-Dewey NEJ, Mullins LL, Chaney JM. Coping style, perceived uncertainty in illness, and distress in individuals with Parkinson's disease and their caregivers. Rehabil Psychol. 2001;46:363–81.CrossRef Sanders-Dewey NEJ, Mullins LL, Chaney JM. Coping style, perceived uncertainty in illness, and distress in individuals with Parkinson's disease and their caregivers. Rehabil Psychol. 2001;46:363–81.CrossRef
23.
go back to reference Mason C. The production and effects of uncertainty with special reference to diabetes mellitus. Soc Sci Med. 1985;21:1329–34.CrossRefPubMed Mason C. The production and effects of uncertainty with special reference to diabetes mellitus. Soc Sci Med. 1985;21:1329–34.CrossRefPubMed
24.
25.
go back to reference Brashers D, Neidig J, Reynolds N, Haas S. Uncertainty in illness across the HIV/AIDS trajectory. J Assoc Nurses AIDS Care. 1998;9:66–77.CrossRefPubMed Brashers D, Neidig J, Reynolds N, Haas S. Uncertainty in illness across the HIV/AIDS trajectory. J Assoc Nurses AIDS Care. 1998;9:66–77.CrossRefPubMed
26.
go back to reference O’Brien KK, Bayoumi AM, Strike C, Young NL, Davis AM. Exploring disability from the perspective of adults living with HIV/AIDS: development of a conceptual framework. Helath Qual Life Out. 2008;6:76.CrossRef O’Brien KK, Bayoumi AM, Strike C, Young NL, Davis AM. Exploring disability from the perspective of adults living with HIV/AIDS: development of a conceptual framework. Helath Qual Life Out. 2008;6:76.CrossRef
27.
go back to reference Bailey DE, Landerman L, Barroso J, Bixby P, Mishel MH, Muir AJ, et al. Uncertainty, symptoms and quality of life in persons with chronic hepatitis C undergoing watchful waiting. Psychosomatics. 2009;50(2):138–46.CrossRefPubMedPubMedCentral Bailey DE, Landerman L, Barroso J, Bixby P, Mishel MH, Muir AJ, et al. Uncertainty, symptoms and quality of life in persons with chronic hepatitis C undergoing watchful waiting. Psychosomatics. 2009;50(2):138–46.CrossRefPubMedPubMedCentral
28.
go back to reference Rhodes T, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction. 2004;99(5):621–33.CrossRefPubMed Rhodes T, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction. 2004;99(5):621–33.CrossRefPubMed
29.
go back to reference Hellard M, McBryde E, Davis RS, Rolls DA, Higgs P, Aitken C, et al. Hepatitis C transmission and treatment as prevention - the role of the injecting network. Int J Drug Policy. 2015;26:958–62.CrossRefPubMed Hellard M, McBryde E, Davis RS, Rolls DA, Higgs P, Aitken C, et al. Hepatitis C transmission and treatment as prevention - the role of the injecting network. Int J Drug Policy. 2015;26:958–62.CrossRefPubMed
30.
go back to reference Liamputtong P, Ezzy D. Qualitative research methods. 2nd ed. Oxford: Oxford University Press; 2005. Liamputtong P, Ezzy D. Qualitative research methods. 2nd ed. Oxford: Oxford University Press; 2005.
31.
go back to reference Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995;311:42–5.CrossRefPubMedPubMedCentral Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ. 1995;311:42–5.CrossRefPubMedPubMedCentral
32.
go back to reference Conrad S, Garrett LE, Cooksley WG, Dunne MP, MacDonald GA. Living with chronic hepatitis C means ‘you just haven’t got a normal life any more’. Chronic Illn. 2006;2:121–31.PubMed Conrad S, Garrett LE, Cooksley WG, Dunne MP, MacDonald GA. Living with chronic hepatitis C means ‘you just haven’t got a normal life any more’. Chronic Illn. 2006;2:121–31.PubMed
33.
go back to reference Treloar C, Rhodes T. The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis. Qual Health Res. 2009;19:1321–34.CrossRefPubMed Treloar C, Rhodes T. The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis. Qual Health Res. 2009;19:1321–34.CrossRefPubMed
34.
go back to reference Lancaster K, Santana L, Madden A, Ritter A. Stigma and subjectivities: examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs. Drugs Educ Prev Policy. 2015;22:224–31.CrossRef Lancaster K, Santana L, Madden A, Ritter A. Stigma and subjectivities: examining the textured relationship between lived experience and opinions about drug policy among people who inject drugs. Drugs Educ Prev Policy. 2015;22:224–31.CrossRef
35.
go back to reference Butt G, Paterson BL, McGuinness LK. Living with the stigma of hepatitis C. West J Nurs Res. 2008;30:204–23.CrossRefPubMed Butt G, Paterson BL, McGuinness LK. Living with the stigma of hepatitis C. West J Nurs Res. 2008;30:204–23.CrossRefPubMed
36.
go back to reference Khaw F-M, Stobbart L, Murtagh MJ. ‘I just keep thinking I haven’t got it because I’m not yellow’: a qualitative study of the factors that influence the uptake of hepatitis C testing by prisoners. BMC Public Health. 2007;7:98.CrossRefPubMedPubMedCentral Khaw F-M, Stobbart L, Murtagh MJ. ‘I just keep thinking I haven’t got it because I’m not yellow’: a qualitative study of the factors that influence the uptake of hepatitis C testing by prisoners. BMC Public Health. 2007;7:98.CrossRefPubMedPubMedCentral
37.
go back to reference Lally MA, Montstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM. A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care ST. 2008;22:53–64.CrossRef Lally MA, Montstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM. A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care ST. 2008;22:53–64.CrossRef
38.
go back to reference Treloar C, Hull P, Dore GJ, Grebely J. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug Alcohol Rev. 2012;31:918–24.CrossRefPubMed Treloar C, Hull P, Dore GJ, Grebely J. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug Alcohol Rev. 2012;31:918–24.CrossRefPubMed
39.
go back to reference Royer A. Uncertainty: a key characteristic of chronic illness and a major problem for managed care. In: Kronenfeld J, editor. Health, illness, and use of care: the impact of social factors. United Kingdom: Emerald Group Publishing Limited; 2000. p. 269–86.CrossRef Royer A. Uncertainty: a key characteristic of chronic illness and a major problem for managed care. In: Kronenfeld J, editor. Health, illness, and use of care: the impact of social factors. United Kingdom: Emerald Group Publishing Limited; 2000. p. 269–86.CrossRef
40.
go back to reference Björnsson E, Verbaan H, Oksanen A, Frydén A, Johansson J, Friberg S, et al. Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scan J Gastroenterol. 2009;44:878–87.CrossRef Björnsson E, Verbaan H, Oksanen A, Frydén A, Johansson J, Friberg S, et al. Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. Scan J Gastroenterol. 2009;44:878–87.CrossRef
41.
go back to reference Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, et al. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007;46:420–31.CrossRefPubMed Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, et al. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007;46:420–31.CrossRefPubMed
43.
go back to reference Bager T, Jensen N, Øvrehus A, PB. C, Nielsen D, editors. “I got my life back!”- Patients’ experiences on being cured for hepatitis C: a qualitative study of fatigue and everyday life in a group of danish patients. 5th International Symposium on Hepatitis Care in Substance Users; 2016; Oslo. Bager T, Jensen N, Øvrehus A, PB. C, Nielsen D, editors. “I got my life back!”- Patients’ experiences on being cured for hepatitis C: a qualitative study of fatigue and everyday life in a group of danish patients. 5th International Symposium on Hepatitis Care in Substance Users; 2016; Oslo.
45.
go back to reference von Bibra S, Doyle JS, Higgs P, Dietze P, Desmond P, Stoove M, et al. Feasibiliy of recruiting people who inject drugs into a nurse-led model of care trial: the tap study. J Hepatol. 2016;64(2):S817–S8.CrossRef von Bibra S, Doyle JS, Higgs P, Dietze P, Desmond P, Stoove M, et al. Feasibiliy of recruiting people who inject drugs into a nurse-led model of care trial: the tap study. J Hepatol. 2016;64(2):S817–S8.CrossRef
Metadata
Title
Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study
Authors
Stelliana Goutzamanis
Joseph S. Doyle
Alexander Thompson
Paul Dietze
Margaret Hellard
Peter Higgs
on behalf of the TAP study group
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3057-1

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue